BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 18, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
March 2, 2005
View Archived Issues
OX-22 completes efficacy study for insomnia
Read More
Mylan and King call off merger
Read More
Archimedes Pharma extends nasal drug delivery collaboration with Ionix
Read More
FDA extends PDUFA action date for nebivolol NDA
Read More
Orphan drug designation for Bronchitol in bronchiectasis
Read More
Sosei seeks Japanese approval for SOT-375
Read More
Intarcia begins phase III study for advanced breast cancer
Read More
MEM-3454 studied in phase I trial
Read More
BCY LifeSciences and Align sign agreement for DCF-987
Read More
Positive phase I findings for CYT006-AngQb for hypertension
Read More
Cytos Biotechnology reports 2004 achievements
Read More
Seikagaku completes phase I/II trial of SI-6603 for lumbar disc herniation
Read More
Recombinant human growth hormone studied in HIV+ patients with lipodystrophy
Read More
Tasmar receives European approval
Read More
Approvable letter for Glumetza
Read More
Second mutation in EGFR kinase domain confers resistance to gefitinib or erlotinib
Read More
Evidence supports the use of nicotine replacement therapies in heavy smokers
Read More
Allopurinol shows promise as add-on therapy for refractory schizophrenia
Read More
Chondroitinase shows promise in the management of spinal cord injuries
Read More
Prime-boost vaccine regimen active in infants of HIV-infected mothers
Read More
Extended treatment improves tacrolimus efficacy in myasthenia gravis
Read More
Modulators of amyloid beta levels claimed by Neurogenetics for Alzheimer's disease
Read More
Chemokine CCR5 receptor activators claimed by Ono
Read More
Eisai scientists disclose the neuroprotective activity of donepezil hydrochloride
Read More
Novel ALK-5 receptor inhibitors imparted by GSK
Read More
Bayer describes novel PDE9A inhibitors for Alzheimer's disease
Read More
AstraZeneca imparts the synthesis of three series of H+/K+-ATPase inhibitors
Read More